| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 |
| Net income | -0.0 | -0.0 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC, OTC: GWLL. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Goldenwell Biotech, Inc.: key numbers
- Share price
- $0.6000Close, Nov 16
- Market cap
- $59.4M
- Shares outstanding
- 99MLatest SEC cover page
- Sector
- Manufacturing
- Industry
- Food and Kindred ProductsSIC 2000
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Goldenwell Biotech, Inc.
All →Goldenwell Biotech Leadership Change
Goldenwell Biotech, Inc. appointed Ming Zhou to its board of directors, effective October 8, 2026. In connection with the appointment, CEO Shuang Liu gifted 20,000,000 shares of common stock to Ms. Zhou, representing approximately 20.2% of the company's outstanding shares.
- Counterparty
- Ming Zhou